*Sponsored by Lifewater Media. Please see disclosures below. |
| | | | | | | Hey Folks, We have an exciting idea for you today... CERo Therapeutics is an innovative immunotherapy company seeking to advance the next generation of engineered T-cell therapeutics. | | | The company is creating a new cancer treatment that uses specially engineered T-cells to fight tumors in a smarter way. These T-cells have a special tool called a chimeric engulfment receptor (CER) that helps them find and attack cancer cells.
Why is this novel treatment methodology a big deal?
|  | Because it allows for a unique combination of both phagocytosis and lysis which separates CERo from the rest of the pack! This means that an FDA breakthrough could have a big impact on the bottom line of the company, something investors will be closely watching. Speaking of FDA progress... | | | CERo has three promising therapy candidates in development, including one for AML currently in Phase 1 trials and two others—targeting ovarian and NSCLC solid tumors—advancing through the preclinical stage. This translates to a number of FDA catalyst opportunities for 2025,.. Positive announcements from the company regarding some of these results could turn the party into a full on fiesta! | | | This is especially true given CERO's low float! A float of only 3.66 million means that a few perma-bulls could change the entire technical dynamic of the stock. | | | Anyways...
That's all for now! Until Next Time, -Damian | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Sponsored by Lifewater Media. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to diansastroxz.forex@blogger.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated seventeen thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for CERo Therapeutics Holdings, Inc. (CERO) from April 23, 2025 to April 24, 2025. ZipTrader may receive additional campaigns in the future by Lifewater Media to distribute media for CERo Therapeutics Holdings, Inc. (CERO). As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in CERo Therapeutics Holdings, Inc. (CERO). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of CERo Therapeutics Holdings, Inc. (CERO), increased trading volume, and possibly an increased share price of CERo Therapeutics Holdings, Inc. (CERO), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. |
| | |
|
|
|---|
|
|
|
Post a Comment
Post a Comment